特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
915204

抗喘息薬・COPD治療薬の世界市場

Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

出版日: | 発行: The Business Research Company | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
抗喘息薬・COPD治療薬の世界市場
出版日: 2020年04月28日
発行: The Business Research Company
ページ情報: 英文
納期: 2-3営業日
担当者のコメント
英国の調査会社、The Business Research Company社(TBRC)より、各告別のCOVID 19の影響下を考慮した抗喘息薬・COPD治療薬の最新動向をまとめた調査レポートがリリースされました。市場データは、2030年度までのForecastを、それぞれ薬剤クラス別、エンドユース別、流通チャネル別にまとめております。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、抗喘息薬・COPD治療薬の世界市場について調査し、市場の特徴、市場規模の推移と予測、セグメント・地域・国別の市場動向、競合情勢、主要企業のプロファイルなどについて包括的にまとめています。

第1章 エグゼクティブサマリー

第2章 抗喘息薬・COPD治療薬市場の特徴

第3章 抗喘息薬・COPD治療薬市場の規模・成長率

  • 世界の抗喘息薬・COPD治療薬市場実績
  • 世界の抗喘息薬・COPD治療薬市場予測

第4章 抗喘息薬・COPD治療薬市場の区分

  • 世界の抗喘息薬・COPD治療薬市場区分:薬剤クラス別の実績・予測
  • 世界の抗喘息薬・COPD治療薬市場区分:エンドユーザー別の実績・予測
  • 世界の抗喘息薬・COPD治療薬市場区分:流通チャネル別の実績・予測

第5章 抗喘息薬・COPD治療薬市場の地域・国別の分析

  • 世界の抗喘息薬・COPD治療薬市場区分:地域別の実績・予測
  • 世界の抗喘息薬・COPD治療薬市場区分:国別の実績・予測

第6章 アジア太平洋の抗喘息薬・COPD治療薬市場

  • 市場概要
  • 市場区分:薬剤クラス別の実績・予測
  • 市場区分:エンドユーザー別の実績・予測

第7章 中国の抗喘息薬・COPD治療薬市場

第8章 インドの抗喘息薬・COPD治療薬市場

第9章 日本の抗喘息薬・COPD治療薬市場

第10章 オーストラリアの抗喘息薬・COPD治療薬市場

第11章 インドネシアの抗喘息薬・COPD治療薬市場

第12章 韓国の抗喘息薬・COPD治療薬市場

第13章 西欧の抗喘息薬・COPD治療薬市場

第14章 英国の抗喘息薬・COPD治療薬市場

第15章 ドイツの抗喘息薬・COPD治療薬市場

第16章 フランスの抗喘息薬・COPD治療薬市場

第17章 東欧の抗喘息薬・COPD治療薬市場

第18章 ロシアの抗喘息薬・COPD治療薬市場

第19章 北米の抗喘息薬・COPD治療薬市場

第20章 米国の抗喘息薬・COPD治療薬市場

第21章 南米の抗喘息薬・COPD治療薬市場

第22章 ブラジルの抗喘息薬・COPD治療薬市場

第23章 中東の抗喘息薬・COPD治療薬市場

第24章 アフリカの抗喘息薬・COPD治療薬市場

第25章 競合情勢・企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Novartis AG
    • Merck & Co
    • GlaxoSmithKline
    • Boehringer Ingelheim Gmbh
    • AstraZeneca

第26章 主なM&A

第27章 市場動向・戦略

第28章 製品パイプライン分析

第29章 将来展望・潜在性の分析

第30章 付録

目次

‘Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the demand for anti-asthmatics and COPD drugs market which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the anti-asthmatics and COPD drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The global anti-asthmatics and COPD drugs market opportunities and strategies to 2030: COVID 19 Implications and Growth report ’ from The Business Research Company answers all these questions and many more.

The report covers the following chapters:

  • 1. Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • 2. Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • 3. Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
  • 4. Market Characteristics - The market characteristics section of the report defines and explains the anti-asthmatics and COPD drugs market. This chapter includes different goods covered in the report and basic definitions.
  • 5. Supply Chain - The supply chain section of the report defines and explains the key players in the anti-asthmatics and COPD drugs industry supply chain.
  • 6. Product Analysis - The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • 7. Top 10 Leading Drugs Sales- The section describes list of top 10 drugs and their sales in the anti-asthmatics and COPD drug market in 2019. It briefs on the drug chemical composition, drug class and the manufacturers involved in manufacturing and selling of these leading drugs in the anti-asthmatics and COPD drugs market.
  • 8. Patent Analysis Of Leading Drugs- The section briefs on the patent analysis of the leading drugs in the anti-asthmatics and COPD drugs market, by focusing on the leading drugs' patent expiry and emergence of the generic drugs in the market.
  • 9. Customer Information - This chapter covers recent customers' trends/preferences in the global anti-asthmatics and COPD drugs market.
  • 10. Impact Of COVID-19 - This section describes the impact of COVID-19 on the anti-asthmatics and COPD drugs market.
  • 11. Trends And Strategies - This chapter describes the major trends shaping the global anti-asthmatics and COPD drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • 12. Asthma And COPD Prevalence Overview - This section describes about asthma and COPD and their prevalence in the major countries.
  • 13. Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019 - 2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • 14. Regional And Country Analysis - This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  • 15. Market Segmentation - This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments in the market.
  • 16. Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • 17. Competitive Landscape - This section covers details on the competitive landscape of the global anti-asthmatics and COPD drugs market, estimated market shares and company profiles of the leading players.
  • 18. Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • 19. Market Background - This section describes the respiratory diseases drugs market of which the anti-asthmatics and COPD drugs market is a segment. This chapter includes the respiratory diseases drugs market 2015-23 values, and regional analyses for the respiratory diseases drugs market.
  • 20. Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • 21. Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-asthmatics and COPD drugs providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
  • 22. Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs
  • By Type Of End-User: Asthma Patients; COPD Patients
  • By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers
  • By Age Group: Below 5 Years
    • 5 to 14 Years
    • 15-69 Years
    • 70+ Years
  • By Type Of Therapy: Preventive; Curative
  • By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral
  • By Type Of Prescription: Prescription; OTC
  • By Type Of Drug: Branded; Generics
  • Companies Mentioned: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis
  • Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Russia, UK, Germany, France, Brazil.
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
  • Time series: Two five-year periods, one three-year period and one six-year period.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Anti-Asthmatics And COPD Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Drug Class
    • 6.1.3. Segmentation By End User
    • 6.1.4. Segmentation By Distribution Channel
    • 6.1.5. Segmentation By Therapy
    • 6.1.6. Segmentation By Route Of Administration
    • 6.1.7. Segmentation By Age Group
    • 6.1.8. Segmentation By Prescription
    • 6.1.9. Segmentation By Drug Type

7. Anti-Asthmatics And COPD Drugs Market Characteristics

  • 7.1. Market Segmentation By Class
    • 7.1.1. Bronchodilators
    • 7.1.2. Anti-Inflammatory Drugs
    • 7.1.3. Monoclonal Antibodies
    • 7.1.4. Combination Drugs
  • 7.2. Market Segmentation By End User
    • 7.2.1. Asthma Patients
    • 7.2.2. COPD Patients
  • 7.3. Market Segmentation By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. General Pharmacies
    • 7.3.3. Online Retailers
  • 7.4. Market Segmentation By Therapy
    • 7.4.1. Preventive
    • 7.4.2. Curative
  • 7.5. Market Segmentation By Route Of Administration
    • 7.5.1. Oral
    • 7.5.2. Inhaled
    • 7.5.3. Intravenous
    • 7.5.4. Subcutaneous
  • 7.6. Market Segmentation By Age Group
    • 7.6.1. Below 5
    • 7.6.2. 5-14
    • 7.6.3. 15-60
    • 7.6.4. Above 60
  • 7.7. Market Segmentation By Prescription
    • 7.7.1. Prescription
    • 7.7.2. Over The Counter (OTC)
  • 7.8. Market Segmentation By Drug Type
    • 7.8.1. Branded
    • 7.8.2. Generic

8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis

    • 8.1.1. Raw Material And Equipment Procurement
    • 8.1.2. Manufacturing, Processing and Packaging
    • 8.1.3. Distribution
    • 8.1.4. Physicians
    • 8.1.5. End users

9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales

    • 10.1.1. Ellipta
    • 10.1.2. Spiriva
    • 10.1.3. Symbicort
    • 10.1.4. Advair
    • 10.1.5. Pulmicort
    • 10.1.6. Ventolin
    • 10.1.7. Xolair
    • 10.1.8. Nucala
    • 10.1.9. Flovent
    • 10.1.10. Fasenra

11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs

    • 11.1.1. Background
    • 11.1.2. Innovators

12. Anti-Asthmatics And COPD Drugs Market, Customer Information

  • 12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese
  • 12.2. Britons Experience Inadequate Treatment Of COPD
  • 12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers
  • 12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits
  • 12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues

13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market

  • 13.1. Consumer Perception
  • 13.2. High Mortality Among Asthma Patients
  • 13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment

14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

    • 14.1.1. India
    • 14.1.2. China
    • 14.1.3. Japan
    • 14.1.4. Australia
    • 14.1.5. South Korea
    • 14.1.6. Indonesia
    • 14.1.7. USA
    • 14.1.8. Canada
    • 14.1.9. Mexico
    • 14.1.10. UK
    • 14.1.11. Germany
    • 14.1.12. France
    • 14.1.13. Russia
    • 14.1.14. Brazil

15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies

  • 15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market
  • 15.2. Increasing Demand For Personalized Medicines
  • 15.3. Demand For Aerosol Respiratory Drugs
  • 15.4. Use Of Biomarker For Precision Medicine
  • 15.5. Rise Of Generic Respiratory Drugs
  • 15.6. Combination Drug Therapy To Treat COPD
  • 15.7.New Biologic Therapy Medicines To Treat Severe Asthma

16. Asthma And COPD Prevalence Overview

  • 16.1. Asthma
  • 16.2. COPD

17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth

  • 17.1. Market Size
  • 17.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 17.2.1. Historic Drivers Of The Market 2015-2019
    • 17.2.2. Historic Restraints Of The Market 2015-2019
  • 17.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 17.3.1. Forecast Drivers Of The Market 2019-2023
    • 17.3.2. Forecast Restraints Of The Market 2019-2023

18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis

  • 18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Global Anti-Asthmatics And COPD Drugs Market Segmentation

  • 19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.1.1. Combination Drugs
    • 19.1.2. Bronchodilators
    • 19.1.3. Monoclonal Antibodies
    • 19.1.4. Anti-Inflammatory Drugs
  • 19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.2.1. Asthma Patients
    • 19.2.2. COPD Patients
  • 19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 19.3.1. General Pharmacies
    • 19.3.2. Hospital Pharmacies
    • 19.3.3. Online Retailers
  • 19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value ($ Million)
    • 19.4.1. Preventive
    • 19.4.2. Curative
  • 19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value ($ Million)
    • 19.5.1. Inhaled
    • 19.5.2. Intravenous and Subcutaneous
    • 19.5.3. Oral
  • 19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019, Value ($ Million)
    • 19.6.1. 15-69 Years
    • 19.6.2. 70+ Years
    • 19.6.3. Below 5 Years
  • 19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value ($ Million)
    • 19.7.1. Prescription
    • 19.7.2. OTC
  • 19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value ($ Million)
    • 19.8.1. Branded
    • 19.8.2. Generics

20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market

  • 20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Government Initiatives
    • 20.1.5. New Drug Trials And Approvals
    • 20.1.6. Major Associations
    • 20.1.7. Taxes Levied
    • 20.1.8. Investments
    • 20.1.9. Major Companies
  • 20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis
  • 20.7. China Anti-Asthmatics And COPD Drugs Market
  • 20.8. China Anti-Asthmatics And COPD Drugs Market Overview
    • 20.8.1. Country Information
    • 20.8.2. Market Information
    • 20.8.3. Background Information
    • 20.8.4. Government Initiatives
    • 20.8.5. New Drug Trials And Approvals
    • 20.8.6. Major Associations
    • 20.8.7. Taxes Levied
    • 20.8.8. Investments
    • 20.8.9. Major Companies
  • 20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.13. India Anti-Asthmatics And COPD Drugs Market
  • 20.14. India Anti-Asthmatics And COPD Drugs Market Overview
    • 20.14.1. Country Information
    • 20.14.2. Market Information
    • 20.14.3. Background Information
    • 20.14.4. Government Initiatives
    • 20.14.5. Major Associations
    • 20.14.6. Taxes Levied
    • 20.14.7. Investments
    • 20.14.8. Major Companies
  • 20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.19. Japan Anti-Asthmatics And COPD Drugs Market
  • 20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview
    • 20.20.1. Country Information
    • 20.20.2. Market Information
    • 20.20.3. Background Information
    • 20.20.4. Government Initiatives
    • 20.20.5. New Drug Trials And Approvals
    • 20.20.6. Major Associations
    • 20.20.7. Taxes Levied
    • 20.20.8. Investments
    • 20.20.9. Major Companies
  • 20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.25. Australia Anti-Asthmatics And COPD Drugs Market
  • 20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.30. Indonesia Anti-Asthmatics And COPD Drugs Market
  • 20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.35. South Korea Anti-Asthmatics And COPD Drugs Market
  • 20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. Western Europe Anti-Asthmatics And COPD Drugs Market

  • 21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Government Initiatives
    • 21.1.5. New Drug Trials And Approvals
    • 21.1.6. Major Associations
    • 21.1.7. Taxes Levied
    • 21.1.8. Major Companies
  • 21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
  • 21.7. UK Anti-Asthmatics And COPD Drugs Market
  • 21.8. UK Anti-Asthmatics And COPD Drugs Market Overview
    • 21.8.1. Country Information
    • 21.8.2. Market Information
    • 21.8.3. Background Information
    • 21.8.4. Government Initiatives
    • 21.8.5. New Drug Trials And Approvals
    • 21.8.6. Major Associations
    • 21.8.7. Taxes Levied
    • 21.8.8. Major Companies
  • 21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.13. Germany Anti-Asthmatics And COPD Drugs Market
  • 21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.18. France Anti-Asthmatics And COPD Drugs Market
  • 21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

22. Eastern Europe Anti-Asthmatics And COPD Drugs Market

  • 22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. New Drug Trials And Approvals
    • 22.1.5. Major Associations
    • 22.1.6. Taxes Levied
    • 22.1.7. Major Companies
  • 22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.6. Russia Anti-Asthmatics And COPD Drugs Market
  • 22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

23. North America Anti-Asthmatics And COPD Drugs Market

  • 23.1. North America Anti-Asthmatics And COPD Drugs Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Background Information
    • 23.1.4. Government Initiatives
    • 23.1.5. New Drug Trials And Approvals
    • 23.1.6. Major Associations
    • 23.1.7. Taxes Levied
    • 23.1.8. Investments
    • 23.1.9. Major Companies
  • 23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis
  • 23.7. USA Anti-Asthmatics And COPD Drugs Market
  • 23.8. USA Anti-Asthmatics And COPD Drugs Market Overview
    • 23.8.1. Country Information
    • 23.8.2. Market Information
    • 23.8.3. Background Information
    • 23.8.4. Government Initiatives
    • 23.8.5. Major Associations
    • 23.8.6. Taxes Levied
    • 23.8.7. Investments
    • 23.8.8. Major Companies
  • 23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

24. South America Anti-Asthmatics And COPD Drugs Market

  • 24.1. South America Anti-Asthmatics And COPD Drugs Market Overview
    • 24.1.1. Region Information
    • 24.1.2. Market Information
    • 24.1.3. Background Information
    • 24.1.4. Major Associations
    • 24.1.5. Government Initiatives
    • 24.1.6. Investments
    • 24.1.7. Major Companies
  • 24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis
  • 24.7. Brazil Anti-Asthmatics And COPD Drugs Market
  • 24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

25. Middle East Anti-Asthmatics And COPD Drugs Market

  • 25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
    • 25.1.1. Region Information
    • 25.1.2. Market Information
    • 25.1.3. Background Information
    • 25.1.4. Government Initiatives
    • 25.1.5. Major Associations
    • 25.1.6. Taxes Levied
    • 25.1.7. Major Companies
  • 25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

26. Africa Anti-Asthmatics And COPD Drugs Market

  • 26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
    • 26.1.1. Region Information
    • 26.1.2. Market Information
    • 26.1.3. Background Information
    • 26.1.4. Government Initiatives
    • 26.1.5. Major Associations
    • 26.1.6. Taxes Levied
    • 26.1.7. Investments
    • 26.1.8. Major Companies
  • 26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape

  • 27.1. Company Profiles
  • 27.2. GlaxoSmithKline plc.
    • 27.2.1. Company Overview
    • 27.2.2. Products And Services
    • 27.2.3. Business Strategy
    • 27.2.4. Financial Overview
  • 27.3. AstraZeneca plc.
    • 27.3.1. Company Overview
    • 27.3.2. Products And Services
    • 27.3.3. Business Strategy
    • 27.3.4. Financial Overview
  • 27.4. Boehringer-Ingelheim GmbH
    • 27.4.1. Company Overview
    • 27.4.2. Products And Services
    • 27.4.3. Business Strategy
    • 27.4.4. Financial Overview
  • 27.5. F. Hoffmann-La Roche Ltd
    • 27.5.1. Company Overview
    • 27.5.2. Products And Services
    • 27.5.3. Business Strategy
    • 27.5.4. Financial Overview
  • 27.6. Novartis AG
    • 27.6.1. Company Overview
    • 27.6.2. Products And Services
    • 27.6.3. Business Strategy
    • 27.6.4. Financial Overview

28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market

  • 28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical
  • 28.2. ResMed Acquired Propeller Health
  • 28.3. Circassia Acquired AstraZeneca's COPD Treatment Tudorza
  • 28.4. RecipharmAB Acquired Sanofi's Inhalation Contract Manufacturing Business
  • 28.5. Mast Therapeutics, Inc. Merged With Savara Inc.
  • 28.6. Mylan N.V. Acquired Majority Stake In Meda AB
  • 28.7. Vectura Group Merged With Skyepharma
  • 28.8. Recordati Acquired Italchimici S.p.A.
  • 28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc.

29. Market Background: Respiratory Diseases Drugs Market

  • 29.1. Respiratory Diseases Drugs Market Characteristics
    • 29.1.1. Market Definition
    • 29.1.2. Segmentation By Type
    • 29.1.3. Anti-Asthmatics And COPD Drugs
    • 29.1.4. Cough And Cold Preparations
  • 29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2023, Value ($ Billion)
  • 29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
  • 29.4. Global Respiratory Diseases Drugs Market, 2015 - 2023, Historic And Forecast, By Region

30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies

  • 30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023 - Countries Offering Most New Opportunities
  • 30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities
  • 30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023 - Growth Strategies
    • 30.3.1. Market Trend Based Strategies
    • 30.3.2. Competitor Strategies

31. Global Anti-Asthmatics And COPD Drugs Market Recommendations

  • 31.1. Conclusions
  • 31.2. Recommendations
    • 31.2.1. Product
    • 31.2.2. Place
    • 31.2.3. Price
    • 31.2.4. Promotion

32. Appendix

  • 32.1. Market Data Sources
  • 32.2. Research Methodology
  • 32.3. Currencies
  • 32.4. Research Inquiries
  • 32.5. The Business Research Company
  • 32.6. Copyright and Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.